Cat Feline Infectious Peritonitis: Welfare Revolution Through Antiviral Treatment

How the development of effective antiviral treatments for FIP has transformed welfare outcomes for cats with this previously fatal disease.

Key Facts

Feline infectious peritonitis (FIP) was previously almost universally fatal in cats
GS-441524 and related antivirals have achieved remission rates exceeding 85% in clinical studies
Treatment requires daily injections or oral medication for 84 days minimum
Cost of treatment has historically been very high but generic options are improving access
Early diagnosis before severe neurological or ocular involvement improves outcomes significantly
FIP remission has transformed from impossible to achievable for many cat owners

Welfare Considerations

The FIP treatment revolution represents one of the most dramatic welfare improvements in companion animal medicine in recent decades. Cats with FIP previously faced inevitable death, often following significant suffering from fluid accumulation, organ failure, or neurological disease. The availability of effective antivirals has transformed prognosis completely, offering genuine cure for most affected cats. The main remaining welfare challenge is access - treatment costs have been prohibitive for many owners, leading to unnecessary euthanasia of treatable cats. Improving affordable access to FIP antivirals globally remains an important veterinary welfare priority.

What You Can Do

Ask your veterinarian about current FIP treatment options if your cat is diagnosed
Advocate for affordable access to generic FIP antivirals in your country
Support organizations working to improve FIP diagnosis and treatment access
Share awareness of FIP treatment advances with cat-owning friends and communities